跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FASENRA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FASENRA
Authorized
STANDARD
FASENRA
astrazeneca canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2757599649017471
Company
astrazeneca canada inc
Type
Standard
Approval Details
Approval Id
2757599649017471
Drug Approval Canada Name
FASENRA
Product Name
FASENRA
Status
Marketed
Status Date
2018-03-28
Original Market Date
2018-03-28
Din
02473232
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
48:10.20
Atc Original
R03DX10 BENRALIZUMAB
Atc Name
r 03 dx 10
Aig Number
0159970001
Company Name
astrazeneca canada inc
Company Address
1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4
Active Ingredients
BENRALIZUMAB
30 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2757599649017471
Type
Standard
Back to Health Canada Approvals